A comprehensive view of Vaccination/Immunization. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Moderna signs 10-year agreement with Australian federal government, Victorian government to work with Monash University to develop mRNA vaccine manufacturing plant; new plant to make up to 100 million respiratory virus vaccines annually
Published: August 17, 2022 by Xinhua News Agency
Merck collaborating with biotechnology firm Orna Therapeutics to develop, commercialize infectious disease, oncology vaccines and therapeutics based on Orna’s oRNA technology; Merck paid Orna US$150.0M upfront as part of deal
Published: August 17, 2022 by Business Wire
Novavax seeks FDA approval for its protein-based NVX-CoV2373 COVID-19 vaccine for use as a booster dose in adults; the FDA approved the vaccine for emergency use in the US in July
Published: August 17, 2022 by SeeNews Pharmaceuticals
British regulator 1st to OK Moderna's updated COVID booster
Published: August 16, 2022 by Associated Press
European Medicine Agency starts rolling review of Pfizer and Biontech’s BA.4/5 Omicron-adapted COVID-19 vaccine candidate; the companies are manufacturing two versions of the vaccine based on different Omicron subvariants
Published: August 15, 2022 by SeeNews Pharmaceuticals

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count